GHIT Fund R&D Forum 2024

Watch recordings from the 2024 GHIT R&D Forum, where leaders from industry, academia, research institutions, and NGOs gathered in Japan to advance global health R&D through innovative partnerships. The sessions showcase discussions on developing and implementing new technologies and treatments for infectious diseases worldwide. Expert speakers share insights on critical challenges in TB, malaria, and neglected tropical diseases, exploring solutions for low- and middle-income countries. Browse videos below to explore key discussions, or access materials from our 2019 and 2017 Forums.

Speaker

Dr. Mandeep Dhaliwal, Director,
HIV and Health Group, Bureau of Policy and Programme Support,
United Nations Development Programme (UNDP)

Session 1:

Speaker

Session 2:

Speaker

1. Dr. Aya Yajima, Regional Advisor - Neglected Tropical Diseases (NTDs), WHO South-East Asia Region (SEARO) [Video Presentation]
2. Dr. Charles Mowbray, Discovery Director, Drugs for Neglected Diseases initiative (DNDi)
3. Dr. Nobuo Saito, Associate Professor, Institute of Tropical Medicine, Nagasaki University
4. Dr. Masahiro Kajihara, Associate Professor, International Institute for Zoonosis Control, Hokkaido University

Session 3:

Speaker

1. Dr. Paul Willis, VP Head of Early Development, Medicines for Malaria Venture
2. Prof. Arjen Dondorp, Deputy Director and Head of Malaria & Critical Illness Department, Mahidol-Oxford Tropical Medicine Research Unit (MORU)
3. Dr. Eizo Takashima, Associate Professor, Ehime University
4. Prof. Osamu Kaneko, Dean and Professor, Institute of Tropical Medicine, Nagasaki University

Session 4:

Speaker

1. Dr. Peter Warner, Senior Program Officer, Bill & Melinda Gates Foundation
2. Dr. Jeremy Burrows, VP Head of Research Drug Discovery, Medicines for Malaria Venture
3. Ms. Mariko Kitahama, Assistant Manager, NEC Corporation
4. Dr. Keita Wagatsuma, Assistant Professor, Division of International Health, Graduate School of Medical and Dental Sciences, Niigata University

Session 5:

Speaker

1. Dr. Ashley Birkett, Global Head, Bacterial & Parasitic Diseases, PATH
2. Dr. Timothy Endy, CEPI Program Leader for the Disease X Vaccine Library and Chikungunya Vaccines, CEPI
3. Dr. Loice Kikwai, Regulatory Affairs Lead, MARKET ACCESS AFRICA
4. Dr. Oumar Ndiaye, R&D and Technology Transfer Specialist, Institut Pasteur de Dakar